Glencore, the UK trading house that made billionaires of its top executives in a record-breaking flotation four years ago, lost up to a third of its market value earlier this week as investors reacted to fears of a prolonged commodities downturn. Matthew Vincent asks FT commodities editor Neil Hume whether it can recover.

Hosted on Acast. See acast.com/privacy for more information.

Barclays has been at loggerheads with Britain's Serious Fraud Officeover a 2008 deal with Qatar that helped the bank avoid a governmentbailout. Patrick Jenkins discusses the latest twist in thelong-running probe with Caroline Binham, the FT's financial regulationcorrespondent.

Hosted on Acast. See acast.com/privacy for more information.

Jeremy Corbyn's surprise election as leader has left the Labour party in disarray. Ahead of the party's annual conference in Brighton, Jim Pickard, the FT's chief political correspondent, asks FT columnists Philip Stephens and Janan Ganesh how long Corbyn can last at the helm. They also discuss what went wrong with Labour's Blairite wing, what difficulties would be faced by those trying to mount any future leadership coup - and how do they think ordinary voters will react to the new leader of the opposition.

Hosted on Acast. See acast.com/privacy for more information.

Henry Mance discusses what went wrong at Volkswagen with John Gapper, the FT's chief business commentator, dubious pricing behaviour in the pharmaceutical industry, and the apparent waning of the UK Labour party's commitment to the cause of staying in the European Union.

Hosted on Acast. See acast.com/privacy for more information.

Ed Barber and Jay Osgerby, winners of the London Design Medal 2015, discuss their work and the broader significance of the London design festival with design writer Max Fraser

Hosted on Acast. See acast.com/privacy for more information.

Hillary Clinton, the Democratic front runner in the race for the White House, pledged this week to crack down on the growing cost of prescription drugs and out of pocket medical expenses in the United States after Turing Pharmaceuticals announced that it was hiking the price of the drug Daraprim from $13.50 to $750 a pill. Aimee Keane asks David Crow about the sharp falls in biotech stocks that followed and whether plans such as Mrs Clinton's will end price-gouging.Music: "Starday" by Podington Bear.

Hosted on Acast. See acast.com/privacy for more information.

The car industry has been thrown into turmoil after Volkswagen admitted cheating on US emissions tests for its diesel cars. Matthew Vincent discusses the burgeoning scandal with Andy Sharman, FT car industry correspondent.

Hosted on Acast. See acast.com/privacy for more information.

Benjamin Netanyahu is on a lightning visit to Moscow to discuss Russia's military deployments in Syria in a sign of Israel's growing unease over arms transfers in the region. Siona Jenkins talks to John Reed, Financial Times Jerusalem correspondent, about the Israeli prime minister's concerns.

Hosted on Acast. See acast.com/privacy for more information.

A round-up of the best FT coverage this week - featuring the Republican presidential debate, Europe's refugee crisis and the rise of adblockers thanks to Apple's new operating system. Presented by Henry Mance

Hosted on Acast. See acast.com/privacy for more information.

In an excerpt from the latest episode of World Weekly, executive comment editor Mark Vandevelde is joined by Gideon Rachman and Peter Spiegel to discuss how the Eurozone and refugee crises are putting strain on the EU and whether or not the union can weather the storm.Music: "Crystal Echoes" by Sergey Cheremisinov.

Hosted on Acast. See acast.com/privacy for more information.